SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-024938
Filing Date
2017-04-20
Accepted
2017-04-20 17:29:14
Documents
1
Period of Report
2017-04-19
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K a17-11583_18k.htm 8-K 20393
  Complete submission text file 0001104659-17-024938.txt   21631
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36020 | Film No.: 17773711
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences